The DOI matches its Crossref record.
Primary (AL) Hepatic Amyloidosis: Clinical Features and Natural History in 98 Patients
Abstract
The liver is a common site of amyloid deposition in primary systemic amyloidosis. We reviewed the clinical features and natural history of patients with primary systemic amyloidosis and biopsy-proven hepatic involvement who were evaluated at Mayo Clinic from January 1, 1975, to December 31, 1997. The median age of the study group (68 men; 30 women) was 58.5 years. Seventy-one patients (72%) had involuntary weight loss. Hepatomegaly was found in 79 patients (81%). Eighty-two patients (89%) had proteinuria, and 81 patients (86%) had elevated serum alkaline phosphatase levels. Seventy-six patients (83%) had either a serum or urine monoclonal protein. Before liver biopsy, clinicians considered amyloidosis in the differential diagnosis for only 14 patients (26%). None of our patients experienced hepatic rupture or death due to liver biopsy, and only 4 (4%) bled after liver biopsy. The median survival of the 98 patients was 8.5 months. Predictors of a poor prognosis were congestive heart failure, elevated concentrations of bilirubin, and a platelet count greater than 500 x 109/L. In conclusion, clinicians should consider the diagnosis of primary hepatic amyloidosis in patients who present with involuntary weight loss or hepatomegaly. Other clues to the diagnosis include an unexplained elevated serum alkaline phosphatase level, proteinuria, and evidence for hyposplenism (for example, Howell-Jolly bodies on peripheral blood smear). Liver biopsy was safe. Some patients benefit from systemic chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Self-citationMerlini, G., & Stone, M. J. (2006) · Blood · doi:10.1182/blood-2006-03-001164 · Cited by 463
Gastrointestinal Manifestations of Amyloidosis
Ebert, E. C., & Nagar, M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01669.x · Cited by 366
Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis
Feng, D., Edwards, W. D., Oh, J. K., Chandrasekaran, K., Grogan, M., Martinez, M. W., Syed, I. I., Hughes, D. A., Lust, J. A., Jaffe, A. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.697763 · Cited by 305
Self-citationIntracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
Feng, D., Syed, I. S., Martinez, M., Oh, J. K., Jaffe, A. S., Grogan, M., Edwards, W. D., Gertz, M. A., & Klarich, K. W. (2009) · Circulation · doi:10.1161/circulationaha.108.785014 · Cited by 283
Self-citation
Metadata
- Authors
- Park, M. A., Mueller, P. S., Kyle, R. A., Larson, D. R., Plevak, M. F., & Gertz, M. A.
- Venue
- Medicine
- Published
- 2003-09
- Volume
- 82
- Issue
- 5
- Pages
- 291-298
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2061206921
- Cited by
- 263
- References
- 0
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary (AL) Hepatic Amyloidosis: Clinical Features and Natural History in 98 Patients. https://app.cochat.ai/papers/10.1097/01.md.0000091183.93122.c7
- The paper
- Park, M. A., Mueller, P. S., Kyle, R. A., Larson, D. R., Plevak, M. F., & Gertz, M. A. (2003). Primary (AL) Hepatic Amyloidosis: Clinical Features and Natural History in 98 Patients. Medicine. https://doi.org/10.1097/01.md.0000091183.93122.c7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.